← All sectors
Sector 08 · Life Sciences
Lab-enabled space and biomanufacturing.
Wet-lab, dry-lab, GMP manufacturing and technology-transfer campuses.
Prime lab rent
$95 psm
+18% YoY
Vacancy
6%
-4 pp YoY
Prime yield
8.25%
-30 bps YoY
Pipeline (sqm)
180k
+45% YoY
Overview
A different asset — deeper power, taller floors, specialist landlord.
Life sciences real estate is not office with fume hoods. Wet-lab, GMP and cell-and-gene facilities require specialist floorplates, vibration performance, backup power and containment — and specialist owners who understand tenant covenant and technology risk together.
Themes we're tracking
The forces reshaping the sector.
01
Biomanufacturing scale-up
Cell-and-gene and vaccine manufacturing driving GMP demand.
02
Innovation districts
University-anchored clusters emerging as the winning format.
03
Grid and utilities
Power, water and effluent capacity are the binding constraint on site selection.
04
Technology transfer
Publicly-funded incubators graduating tenants into private lab space.
05
Specialist covenant
Underwriting of research pipeline, funding runway and IP alongside financials.
06
Public-private capital
Sovereign and DFI capital co-investing with institutional owners into strategic campuses.
How we help
Mandates we deliver.
01
Occupier representation
Site selection, specification, term negotiation and fit-out oversight for life-science occupiers.
02
Development advisory
Feasibility, MEP specification, phasing and delivery for wet-lab and GMP schemes.
03
Investment
Forward funding, stabilised income and platform-level acquisition and disposal.
04
Valuation
Specialist valuation for lending, IFRS and disposal of lab-enabled space.
05
Cluster strategy
Master planning and tenant-attraction strategy for innovation districts.
Ready to view
See the assets, on site.
Related sectors